222 related articles for article (PubMed ID: 34820133)
1. A Canadian Study of Cisplatin Metabolomics and Nephrotoxicity (ACCENT): A Clinical Research Protocol.
Jain A; Huang R; Lee J; Jawa N; Lim YJ; Guron M; Abish S; Boutros PC; Brudno M; Carleton B; Cuvelier GDE; Gunaratnam L; Ho C; Adeli K; Kuruvilla S; Lajoie G; Liu G; Nathan PC; Rod Rassekh S; Rieder M; Waikar SS; Welch SA; Weir MA; Winquist E; Wishart DS; Zorzi AP; Blydt-Hansen T; Zappitelli M; Urquhart B
Can J Kidney Health Dis; 2021; 8():20543581211057708. PubMed ID: 34820133
[TBL] [Abstract][Full Text] [Related]
2. Design and Methods of the Pan-Canadian Applying Biomarkers to Minimize Long-Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Nephrotoxicity Study: A Prospective Observational Cohort Study.
McMahon KR; Rod Rassekh S; Schultz KR; Pinsk M; Blydt-Hansen T; Mammen C; Tsuyuki RT; Devarajan P; Cuvelier GD; Mitchell LG; Baruchel S; Palijan A; Carleton BC; Ross CJ; Zappitelli M;
Can J Kidney Health Dis; 2017; 4():2054358117690338. PubMed ID: 28270931
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics for the identification of early biomarkers of nephrotoxicity in a mouse model of cisplatin-induced acute kidney injury.
Lim YJ; Tonial NC; Hartjes ED; Haig A; Velenosi TJ; Urquhart BL
Biomed Pharmacother; 2023 Jul; 163():114787. PubMed ID: 37126930
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic identification of predictive and early biomarkers of cisplatin-induced acute kidney injury in adult head and neck cancer patients.
Lim YJ; Xiu SG; Kuruvilla MS; Winquist E; Welch S; Black M; Faught LN; Lee J; Rieder MJ; Blydt-Hansen TD; Zappitelli M; Urquhart BL
Br J Clin Pharmacol; 2023 Jan; ():. PubMed ID: 36657745
[TBL] [Abstract][Full Text] [Related]
5. Identification of key metabolites during cisplatin-induced acute kidney injury using an HPLC-TOF/MS-based non-targeted urine and kidney metabolomics approach in rats.
Qu X; Gao H; Sun J; Tao L; Zhang Y; Zhai J; Song Y; Hu T; Li Z
Toxicology; 2020 Feb; 431():152366. PubMed ID: 31926187
[TBL] [Abstract][Full Text] [Related]
6. Association of Urine Platinum With Acute Kidney Injury in Children Treated With Cisplatin for Cancer.
Lebel A; Chui H; McMahon KR; Lim YJ; Macri J; Wang S; Devarajan P; Blydt-Hansen TD; Zappitelli M; Urquhart BL
J Clin Pharmacol; 2021 Jul; 61(7):871-880. PubMed ID: 33599997
[TBL] [Abstract][Full Text] [Related]
7. Acute kidney injury during cisplatin therapy and associations with kidney outcomes 2 to 6 months post-cisplatin in children: a multi-centre, prospective observational study.
McMahon KR; Lebel A; Rassekh SR; Schultz KR; Blydt-Hansen TD; Cuvelier GDE; Mammen C; Pinsk M; Carleton BC; Tsuyuki RT; Ross CJD; Huynh L; Yordanova M; Crépeau-Hubert F; Wang S; Palijan A; Lee J; Boyko D; Zappitelli M;
Pediatr Nephrol; 2023 May; 38(5):1667-1685. PubMed ID: 36260162
[TBL] [Abstract][Full Text] [Related]
8. Identification of urinary candidate biomarkers of cisplatin-induced nephrotoxicity in patients with carcinoma.
Jiang W; Ma T; Zhang C; Tang X; Xu Q; Meng X; Ma T
J Proteomics; 2020 Jan; 210():103533. PubMed ID: 31629959
[TBL] [Abstract][Full Text] [Related]
9. Altered metabolic profiles and biomarkers associated with astragaloside IV-mediated protection against cisplatin-induced acute kidney injury in rats: An HPLC-TOF/MS-based untargeted metabolomics study.
Song Y; Hu T; Gao H; Zhai J; Gong J; Zhang Y; Tao L; Sun J; Li Z; Qu X
Biochem Pharmacol; 2021 Jan; 183():114299. PubMed ID: 33148504
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin-induced nephrotoxicity in childhood cancer: comparison between two countries.
Zazuli Z; Op 't Hoog CJP; Vijverberg SJH; Masereeuw R; Rassekh SR; Medeiros M; Rivas-Ruiz R; Maitland-van der Zee AH; Carleton BC
Pediatr Nephrol; 2023 Feb; 38(2):593-604. PubMed ID: 35748941
[TBL] [Abstract][Full Text] [Related]
11. Urine ratio of neutrophil gelatinase-associated lipocalin to creatinine as a marker for early detection of cisplatin-associated nephrotoxicity.
Shahbazi F; Sadighi S; Dashti-Khavidaki S; Shahi F; Mirzania M
Iran J Kidney Dis; 2015 Jul; 9(4):306-10. PubMed ID: 26174458
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of urinary neutrophil gelatinase-associated lipocalin and urinary kidney injury molecule-1 as biomarkers of renal function in cancer patients treated with cisplatin.
Ghadrdan E; Ebrahimpour S; Sadighi S; Chaibakhsh S; Jahangard-Rafsanjani Z
J Oncol Pharm Pract; 2020 Oct; 26(7):1643-1649. PubMed ID: 32046578
[TBL] [Abstract][Full Text] [Related]
13. Urine biomarkers of acute kidney injury in noncritically ill, hospitalized children treated with chemotherapy.
Sterling M; Al-Ismaili Z; McMahon KR; Piccioni M; Pizzi M; Mottes T; Lands LC; Abish S; Fleming AJ; Bennett MR; Palijan A; Devarajan P; Goldstein SL; O'Brien MM; Zappitelli M
Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28417544
[TBL] [Abstract][Full Text] [Related]
14. Epidemiologic Characteristics of Acute Kidney Injury During Cisplatin Infusions in Children Treated for Cancer.
McMahon KR; Rassekh SR; Schultz KR; Blydt-Hansen T; Cuvelier GDE; Mammen C; Pinsk M; Carleton BC; Tsuyuki RT; Ross CJD; Palijan A; Huynh L; Yordanova M; Crépeau-Hubert F; Wang S; Boyko D; Zappitelli M;
JAMA Netw Open; 2020 May; 3(5):e203639. PubMed ID: 32383745
[TBL] [Abstract][Full Text] [Related]
15. Understanding the Risk Factors and Long-Term Consequences of Cisplatin-Associated Acute Kidney Injury: An Observational Cohort Study.
Bhat ZY; Cadnapaphornchai P; Ginsburg K; Sivagnanam M; Chopra S; Treadway CK; Lin HS; Yoo G; Sukari A; Doshi MD
PLoS One; 2015; 10(11):e0142225. PubMed ID: 26556481
[TBL] [Abstract][Full Text] [Related]
16. Predicting cisplatin-induced acute kidney injury by urinary neutrophil gelatinase-associated lipocalin excretion: a pilot prospective case-control study.
Gaspari F; Cravedi P; Mandalà M; Perico N; de Leon FR; Stucchi N; Ferrari S; Labianca R; Remuzzi G; Ruggenenti P
Nephron Clin Pract; 2010; 115(2):c154-60. PubMed ID: 20407275
[TBL] [Abstract][Full Text] [Related]
17. Long-term renal follow-up of children treated with cisplatin, carboplatin, or ifosfamide: a pilot study.
McMahon KR; Harel-Sterling M; Pizzi M; Huynh L; Hessey E; Zappitelli M
Pediatr Nephrol; 2018 Dec; 33(12):2311-2320. PubMed ID: 30218190
[TBL] [Abstract][Full Text] [Related]
18. Urinary kidney injury molecule-1 and monocyte chemotactic protein-1 are noninvasive biomarkers of cisplatin-induced nephrotoxicity in lung cancer patients.
Shinke H; Masuda S; Togashi Y; Ikemi Y; Ozawa A; Sato T; Kim YH; Mishima M; Ichimura T; Bonventre JV; Matsubara K
Cancer Chemother Pharmacol; 2015 Nov; 76(5):989-96. PubMed ID: 26407820
[TBL] [Abstract][Full Text] [Related]
19. Urinary NMR Profiling in Pediatric Acute Kidney Injury-A Pilot Study.
Muhle-Goll C; Eisenmann P; Luy B; Kölker S; Tönshoff B; Fichtner A; Westhoff JH
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32054020
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
